In a contradictory report, the US FDA has denied claims by the US president, Donald Trump that they have approved Chloroquine for Coronavirus use.
This was revealed by the U.S. Food and Drug Administration Commissioner Stephen Hahn addressed the ongoing work of the agency in terms of its work on potential treatments and vaccines for the COVID-19 coronavirus currently spreading globally.
This statement contradicts what President Donald Trump made known in a press briefing on Thursday that one proposed treatment, anti-malarial chloroquine, had already been approved by the FDA for COVID-19 treatment.
However, Hahn said that in fact, the agency is currently looking at widespread clinical trials of the drug, but it is not yet approved for that use.
In his statement, Hann said;
“In the short term, we’re looking at drugs that are already approved for other indications. Many Americans have read studies and heard media reports about this drug chloroquine, which is an anti-malarial drug.
It’s already approved, as the president said, for the treatment of malaria [Trump had not said this, but had instead said it was now approved for COVID-19] as well as an arthritis condition. That’s a drug that the president has directed us to take a closer look at, as to whether an expanded use approach to that could be done to actually see if that benefits patients. And again, we want to do that in the setting of a clinical trial, a large pragmatic clinical trial to actually gather that information and answer the question that needs to be answered.”